CA23140 – Boost and secure ATMP for BURN patient (ESENBURN)

ibs.GRANADA · Redes Internacionales

Accidental burns are among the main etiologies of trauma and death with 11 million consultations in hospitals and 300,000 deaths per year worldwide. The main aim and objective of ESENBURN COST action is to create, structure and support a network of biomanufacturers, burn centers, pre-clinical validation sites, regulatory bodies R&D departments to evaluate, boost and secure the clinical applications of advanced therapy medicinal product (ATMPs) for burn patients.

Start of Action: 18/10/2024
End of Action: 17/10/2028
Participant: Jesús Chato Astrain, Salvador Arias Santiago
Group: TEC03-INGENIERÍA TISULAR / TECE19-DERMATOLOGÍA CLÍNICA Y TRASLACIONAL

https://esenburn.eu/about/
https://www.cost.eu/actions/CA23140/